GOLDMAN SACHS GROUP INC - INCYTE CORP ownership

INCYTE CORP's ticker is and the CUSIP is 45337CAN2. A total of 22 filers reported holding INCYTE CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of INCYTE CORP
ValueSharesWeighting
Q1 2020$180,000
-12.6%
122,0000.0%0.00%
Q4 2019$206,000
+13.2%
122,0000.0%0.00%
Q3 2019$182,000
-10.3%
122,0000.0%0.00%
Q2 2019$203,000
-1.0%
122,0000.0%0.00%
Q1 2019$205,000
+28.1%
122,0000.0%0.00%
Q4 2018$160,000
-5.9%
122,0000.0%0.00%
Q3 2018$170,000
+1.8%
122,0000.0%0.00%
Q2 2018$167,000
-16.1%
122,0000.0%0.00%
Q1 2018$199,000
-11.9%
122,0000.0%0.00%
Q4 2017$226,000
-18.7%
122,0000.0%0.00%
Q3 2017$278,000
-8.3%
122,0000.0%0.00%
Q2 2017$303,000
-5.6%
122,0000.0%0.00%
Q1 2017$321,000
+31.6%
122,000
+1.7%
0.00%
Q4 2016$244,000
+5.2%
120,0000.0%0.00%
Q3 2016$232,000
+95.0%
120,000
+71.4%
0.00%
Q2 2016$119,000
+8.2%
70,0000.0%0.00%
Q1 2016$110,000
-95.8%
70,000
-95.9%
0.00%
-100.0%
Q4 2014$2,613,0001,696,0000.00%
Other shareholders
INCYTE CORP shareholders Q1 2015
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 22,232,000$35,092,0001.94%
Nicholas Investment Partners, LP 3,120,000$4,898,0000.36%
CSS LLC/IL 3,500,000$5,577,0000.34%
Hudson Bay Capital Management LP 2,500,000$3,954,0000.19%
ADVENT CAPITAL MANAGEMENT /DE/ 3,937,000$6,226,0000.10%
PALISADE CAPITAL MANAGEMENT, LP 1,402,000$2,216,0000.07%
Orbimed Advisors 4,250,000$6,727,0000.07%
Citadel Advisors 28,500,000$44,936,0000.06%
Calamos Advisors LLC 4,960,000$7,851,0000.05%
GABELLI FUNDS LLC 1,000,000$1,570,0000.01%
View complete list of INCYTE CORP shareholders